Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R FISHER

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Science (New York, N.Y.)|February 12, 1971
A portal blood factor as the humoral agent in liver regenerationB Fisher, P Szuch, M Levine, et al.
Cancer|April 15, 1993
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminantsE R Fisher, S Anderson, C Redmond, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1975
Identification of premalignant hyperplasia in methylcholanthrene-induced mammary tumorogenesisE R Fisher, R H Shoemaker, A S Palekar
Diseases of the Colon and Rectum|November 1, 1989
Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01)E R Fisher, B Robinsky, R Sass, et al.
Breast Cancer Research and Treatment|January 1, 1986
Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancerB Fisher, E R Fisher, C Redmond, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1978
The myofibroblastic nature of the uterine plexiform tumorE R Fisher, J D Paulson, R M Gregorio
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1977
Tumor cells in venous blood draining mammary carcinomasR C Golinger, R M Gregorio, E R Fisher
Cancer|March 15, 1993
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project InvestigatorsE R Fisher, J Costantino, B Fisher, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1983
Types of tumor lymphoid response and sinus histiocytosis. Relationship to five-year, disease-free survival in patients with breast cancerE R Fisher, N Kotwal, C Hermann, et al.
Cancer|December 15, 1984
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancerE R Fisher, B Fisher, R Sass, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Science (New York, N.Y.)|February 12, 1971
A portal blood factor as the humoral agent in liver regenerationB Fisher, P Szuch, M Levine, et al.
Cancer|April 15, 1993
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminantsE R Fisher, S Anderson, C Redmond, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1975
Identification of premalignant hyperplasia in methylcholanthrene-induced mammary tumorogenesisE R Fisher, R H Shoemaker, A S Palekar
Diseases of the Colon and Rectum|November 1, 1989
Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01)E R Fisher, B Robinsky, R Sass, et al.
Breast Cancer Research and Treatment|January 1, 1986
Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancerB Fisher, E R Fisher, C Redmond, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1978
The myofibroblastic nature of the uterine plexiform tumorE R Fisher, J D Paulson, R M Gregorio
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1977
Tumor cells in venous blood draining mammary carcinomasR C Golinger, R M Gregorio, E R Fisher
Cancer|March 15, 1993
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project InvestigatorsE R Fisher, J Costantino, B Fisher, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1983
Types of tumor lymphoid response and sinus histiocytosis. Relationship to five-year, disease-free survival in patients with breast cancerE R Fisher, N Kotwal, C Hermann, et al.
Cancer|December 15, 1984
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancerE R Fisher, B Fisher, R Sass, et al.
Pageof 14